[1]
I. F. Santos, S. Pereira, E. McLeod, A.-L. Guillermin, and I. Chatzitheofilou, “Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal”, Acta Med Port, vol. 27, no. 5, pp. 615–624, Oct. 2014.